Key Developments: Chemometec A/S (CHEMM.CO)

CHEMM.CO on Copenhagen Stock Exchange

5.10DKK
10:38am EDT
Price Change (% chg)

kr.0.50 (+10.87%)
Prev Close
kr.4.60
Open
kr.4.51
Day's High
kr.5.20
Day's Low
kr.4.50
Volume
15,614
Avg. Vol
66,679
52-wk High
kr.5.20
52-wk Low
kr.3.26

Search Stocks

Latest Key Developments (Source: Significant Developments)

ChemoMetec A/S says CEO resigns
Wednesday, 20 Aug 2014 03:06am EDT 

ChemoMetec A/S:Announces that CEO, Steen S√łndergaard, by mutual agreement resigns from his position with effect from Aug. 20.Says Michael Eising, who is Vice Chairman of the Board, will be appointed as CEO.  Full Article

ChemoMetec A/S maintains FY 2013/2014 financial guidance
Thursday, 15 May 2014 02:30am EDT 

ChemoMetec A/S:Says it has maintained its expectations for FY 2013/2014 revenue of between 43 mln Danish crowns and 45 mln crowns and FY 2013/2014 operating profit (EBITDA) in a range of between 6 mln crowns and 8 mln crowns.  Full Article

ChemoMetec A/S enters into research collaboration with Rigshospitalet, Minerva Imaging and Hoejteknologifonden
Monday, 16 Dec 2013 03:04am EST 

ChemoMetec A/S:Says it has signed an agreement for a research collaboration with the Rigshospitalet, Minerva Imaging and Hoejteknologifonden about a new survey method for men with poor sperm quality.Says the project will run for five years and is expected to cost a total of 80 million Danish crowns, of which Hoejteknologifonden has agreed to co-finance 45 million Danish crowns.Says its contribution to the project will be primarily to develop equipment for automatic semen analysis.  Full Article

ChemoMetec A/S Maintains FY 2013/2014 Financial Guidance
Friday, 15 Nov 2013 02:04am EST 

ChemoMetec A/S announced that the Company maintains its fiscal year 2013/2014 financial guidance. The Company still expects its revenue to be in the DKK 43-45 million range and EBITDA to be in a level of DKK 6-8 million in the fiscal year 2013/2014.  Full Article

ChemoMetec A/S Announces Chief Executive Officer Change
Thursday, 31 Oct 2013 05:34am EDT 

ChemoMetec A/S announced that the Company's Chief Executive Officer (CEO), Mr. Torsten Freltoft, leaves the position with immediate effect. Mr. Steen Soendergaard-Larsen, Chief Operations Officer of the Company, will act as CEO after Mr. Freltoft leaves his post.  Full Article

Hook Holding Company A/S Divests Entire Stake in ChemoMetec A/S
Tuesday, 1 Oct 2013 08:08am EDT 

ChemoMetec A/S announced that on September 27, 2013 Hook Holding Company A/S sold 1,776,119 shares in the Company. Following the divesture Hook Holding owns no shares in ChemoMetec.  Full Article

ChemoMetec A/S Issues FY 2013/2014 Financial Guidance; Proposes No Dividend for FY 2012/2013
Wednesday, 18 Sep 2013 02:30am EDT 

ChemoMetec A/S announced that it expects to report fiscal year 2013/2014 revenue in a range of between DKK 43 million and DKK 45 million and fiscal year 2013/2014 operating profit (EBITDA) in a range of between DKK 6 million and DKK 8 million. The Company also announced that its Board of Directors proposes to the Annual General Meeting that no dividend be paid for fiscal year 2012/2013.  Full Article

ChemoMetec A/S Announces Mr. Preben Koenig as Chairman
Thursday, 25 Jul 2013 02:50pm EDT 

ChemoMetec A/S announced that the Company's Extraordinary General Meeting appointed Mr. Preben Koenig as new Chairman of the Company's Board of Directors. He will replace Mr. Stig Loekke Pedersen, who leaves the Board. Mr. Koenig has previously served as an ordinary member of the Company's Board.  Full Article

ChemoMetec A/S Appoints Mr. Torsten Freltoft as Chief Executive Officer
Tuesday, 25 Jun 2013 02:57am EDT 

ChemoMetec A/S announced that Mr. Torsten Freltoft has been appointed Chief Executive Officer of the Company. The appointment is effective as of August 17, 2013.  Full Article

ChemoMetec A/S's CEO Martin Glensbjerg Resigns
Thursday, 16 May 2013 03:10am EDT 

ChemoMetec A/S announced that its Chief Executive Officer (CEO) Martin Glensbjerg has decided to resign from his position as of May 16, 2013. Until a new CEO is recruited, the Company's Vice Chairman, Thomas Hartwig, will be Acting CEO.  Full Article

BRIEF-Chemometec 2013/14 revenue up by 9.2 pct to DKK 45.2 mln

* Said on Wednesday 2013/14 revenue was 45.2 million Danish crowns versus 41.4 million crowns

No consensus analysis data available.
Search Stocks